We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Use of Albuterol Multidose Dry Powder Inhaler in Participants With Chronic Obstructive Pulmonary Disease

- Chronic Obstructive Pulmonary Disease
- Completed

Study Title: Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Teva Identifier: ABS-COPD-30065

ClinicalTrials.gov Identifier: NCT03256695

Study Status: Completed

Trial Condition(s): Chronic Obstructive Pulmonary Disease

Interventions: Drug: Albuterol sulfate (ABS)

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 40 Years and older

Trial Duration: September 28, 2017 - April 17, 2018

Phase: Phase 3

Study Type

Interventional